Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy
Titel:
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy
Auteur:
Wenzel, Mike Hoeh, Benedikt Siech, Carolin Koll, Florestan Humke, Clara Groener, Daniel Steuber, Thomas Graefen, Markus Maurer, Tobias Banek, Severine Chun, Felix K. H. Mandel, Philipp
Verschenen in:
European journal of nuclear medicine and molecular imaging